avatar

ASSOCIATE PROF. DR. ADLINDA BINTI ALIP

Department of Oncology Clinical

Faculty of Medicine

adlindaum.edu.my
Statistics
Annual Publications by Category
Summary of Budget vs Expenditure per vote for all research grants
Latest Publications
2023

The outcomes of glioblastoma multiforme: The University Malaya Medical Centre experience 2008-2018

2023

Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial

2023

Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system

2023

Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system

2023

Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment Among Asian Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): MARIPOSA Subgroup Analysis

2023

Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment in Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): Primary Results From MARIPOSA, a Phase 3, Global, Randomized, Controlled Trial

2017

Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting.

2016

Diagnostic Dilemma: A case of Metastatic Tubulocystic Carcinoma of the Kidney.